Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 650 | 724 | 1,284 | 1,829 | 501 |
| Receivables | 3 | 511 | N/A | N/A | N/A |
| TOTAL | $720 | $1,321 | $1,382 | $1,833 | $585 |
| Non-Current Assets | |||||
| PPE Net | 75 | 88 | 103 | 119 | 134 |
| Other Non-Current Assets | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $87 | $99 | $114 | $130 | $146 |
| Total Assets | $807 | $1,420 | $1,496 | $1,963 | $730 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 318 | 429 | 498 | 278 | 356 |
| TOTAL | $318 | $429 | $498 | $278 | $356 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,250 | 2,309 | 2,169 | 2,042 | 1,928 |
| TOTAL | $2,686 | $2,759 | $2,169 | $2,042 | $1,928 |
| Total Liabilities | $3,003 | $3,188 | $2,667 | $2,320 | $2,284 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,655 | 13,590 | 13,565 | 13,490 | 13,490 |
| Common Shares | 32,856 | 32,530 | 32,375 | 32,412 | 30,637 |
| Retained earnings | -35,146 | -34,391 | -33,640 | -32,864 | -32,285 |
| TOTAL | $-2,196 | $-1,767 | $-1,171 | $-357 | $-1,554 |
| Total Liabilities And Equity | $807 | $1,420 | $1,496 | $1,963 | $730 |